Drug–drug interactions & the potential impact on toxicity levels in patients with B-cell malignancy
Prospect of new therapies for AML
Biosimilars and the future of more affordable treatment for hematologic malignancies
The standardization of molecular diagnostics for myeloid diseases in Italy
What are the practical considerations for monoclonal antibody infusion?